What is Enzolytics Inc?
, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.42M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.